Related references
Note: Only part of the references are listed.Predicting Outcomes to Optimize Disease Management in Inflammatory Bowel Diseases
Joana Torres et al.
JOURNAL OF CROHNS & COLITIS (2016)
Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease
E. Safroneeva et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Understanding and Avoiding Immortal-Time Bias in Gastrointestinal Observational Research
Laura E. Targownik et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
L. Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Treatment Steps, Surgery, and Hospitalization Rates During the First Year of Follow-up in Patients with Inflammatory Bowel Diseases from the 2011 ECCO-Epicom Inception Cohort
Z. Vegh et al.
JOURNAL OF CROHNS & COLITIS (2015)
Disease Course and Surgery Rates in Inflammatory Bowel Disease: A Population-Based, 7-Year Follow-Up Study in the Era of Immunomodulating Therapy
Marianne K. Vester-Andersen et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNF alpha therapy: results from the COIN study
Mirthe Emilie van der Valk et al.
GUT (2014)
Are we improving disease outcomes in IBD? A view from the epidemiology side
Corinne Gower-Rousseau et al.
GUT (2014)
Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011
Christine Rungoe et al.
GUT (2014)
Prevalence of and Outcomes Associated with Corticosteroid Prescription in Inflammatory Bowel Disease
Laura E. Targownik et al.
INFLAMMATORY BOWEL DISEASES (2014)
Early Use of Thiopurines or Methotrexate Reduces Major Abdominal and Perianal Surgery in Crohn's Disease
Viraj C. Kariyawasam et al.
INFLAMMATORY BOWEL DISEASES (2014)
Hospitalisation, surgical and medical recurrence rates in inflammatory bowel disease 2003-2011 A Danish population-based cohort study
Marianne K. Vester-Andersen et al.
JOURNAL OF CROHNS & COLITIS (2014)
Moving towards disease modification in inflammatory bowel disease therapy
Patrick B. Allen et al.
CURRENT OPINION IN GASTROENTEROLOGY (2013)
Crohn's disease complicated by strictures: a systematic review
Florian Rieder et al.
GUT (2013)
Evolution of disease phenotype in adult and pediatric onset Crohn's disease in a population-based cohort
Barbara Dorottya Lovasz et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Has There Been a Change in the Natural History of Crohn's Disease? Surgical Rates and Medical Management in a Population-Based Inception Cohort from Western Hungary Between 1977-2009
Peter Laszlo Lakatos et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Clinical Risk Factors for Complicated Disease: How Reliable Are They?
Camille Zallot et al.
DIGESTIVE DISEASES (2012)
Outcomes of Patients With Crohn's Disease Improved From 1988 to 2008 and Were Associated With Increased Specialist Care
Geoffrey C. Nguyen et al.
GASTROENTEROLOGY (2011)
Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease
Laurent Peyrin-Biroulet et al.
GUT (2011)
Risks and benefits of (pharmaco)epidemiology
Lesley Wise
THERAPEUTIC ADVANCES IN DRUG SAFETY (2011)
The Natural History of Adult Crohn's Disease in Population-Based Cohorts
Laurent Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates
A. V. Ramadas et al.
GUT (2010)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
A. Dignass et al.
JOURNAL OF CROHNS & COLITIS (2010)
Immunomodulators Are Associated With a Lower Risk of First Surgery Among Patients With Non-Penetrating Non-Stricturing Crohn's Disease
Michael F. Picco et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Immortal time bias in pharmacoepidemiology
Samy Suissa
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Perianal Disease Predicts Changes in Crohn's Disease Phenotype-Results of a Population-Based Study of Inflammatory Bowel Disease Phenotype
Kelly M. Tarrant et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Clinical course in Crohn's disease: Results of a Norwegian population-based ten-year follow-up study
Inger Camilla Solberg et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Immortal time bias in observational studies of drug effects
Samy Suissa
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
Jean-Frederic Colombel et al.
GASTROENTEROLOGY (2007)
Phenotype at diagnosis predicts recurrence rates in Crohn's disease
F. L. Wolters et al.
GUT (2006)
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
J. Satsangi et al.
GUT (2006)
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial
SB Hanauer et al.
GASTROENTEROLOGY (2006)
Long-term evolution of disease behavior of Crohn's disease
J Cosnes et al.
INFLAMMATORY BOWEL DISEASES (2002)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
WA Faubion et al.
GASTROENTEROLOGY (2001)
Share Paper
